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he internal environment of the ER is regulated to
accommodate  essential cellular processes, yet our
understanding of this regulation remains incomplete.
Cod1p/Spf1p belongs to the widely conserved, uncharac-
terized type V branch of P-type ATPases, a large family of
ion pumps. Our previous work suggested Cod1p may
function in the ER. Consistent with this hypothesis, we
localized Cod1p to the ER membrane. The 
 
cod1
 
 
 
 mutant
disrupted cellular calcium homeostasis, causing increased
transcription of calcium-regulated genes and a synergistic
increase in cellular calcium when paired with disruption of
the Golgi apparatus–localized Ca
 
2
 
 
 
 pump Pmr1p. Deletion
T
 
of 
 
COD1
 
 also impaired ER function, causing constitutive
activation of the unfolded protein response, hypersensitivity
to the glycosylation inhibitor tunicamycin, and synthetic
lethality with deletion of the unfolded protein response
regulator 
 
HAC1
 
. Expression of the 
 
Drosophila melanogaster
 
homologue of Cod1p complemented the 
 
cod1
 
 
 
 mutant.
Finally, we demonstrated the ATPase activity of the puriﬁed
protein. This study provides the ﬁrst biochemical charac-
terization of a type V P-type ATPase, implicates Cod1p in
ER function and ion homeostasis, and indicates that
these functions are conserved among Cod1p’s metazoan
homologues.
 
Introduction
 
The ER is the site of essential cellular processes that require
stringent regulation of lumenal ion levels. The ER also serves
as a source of releasable Ca
 
2
 
 
 
 that can be mobilized for various
cellular demands. Consequently, the ion levels of the ER are
under continuous, dynamic control in order to serve these
essential functions. The ion levels of many membrane com-
partments are maintained by the action of a superfamily of
ATP-dependent ion pumps known as P-type ATPases
(Axelsen and Palmgren, 1998; Scarborough, 1999). These
proteins catalyze ATP-dependent active transport of ions
across numerous cellular membranes. The P-type ATPases
that have been characterized are highly specific, transporting
only a single ion, or sometimes two related ones. However,
there are a large number of P-type ATPases identified solely
by sequence, having unknown function and specificity, that
await assignment of biochemical and physiological func-
tions. In mammals, one mechanism of ER ion regulation
occurs through the action of the sarcoplasmic/endoplasmic
reticulum calcium ATPase (SERCA)* pumps, which are
localized to the ER and belong to the type IIa, calcium-
specific subfamily of P-type ATPases (Carafoli and Brini,
2000; Axelsen and Palmgren, 2001). Although clearly impor-
tant in animals, SERCA pumps are absent in other organisms,
such as fungi, that nevertheless control ER ion content
(Catty et al., 1997; Axelsen and Palmgren, 1998). Thus, it is
likely that a more widely conserved P-type ATPase is respon-
sible for ER ion maintenance in these organisms, and perhaps
play an important, yet until now unsuspected, role in
mammals as well.
Because fungi do not posses SERCA ATPases, the mech-
anisms by which calcium is supplied to the yeast ER had
remained enigmatic. The absence of SERCA pumps led several
groups to suggest that the yeast ER is supplied with calcium
solely by the action of the Golgi-localized pump Pmr1p
(Duerr et al., 1998; Marchi et al., 1999; Strayle et al., 1999).
This model is reasonable because 
 
pmr1
 
 
 
 mutants have a
number of phenotypes related to the function of the ER
(Duerr et al., 1998; Strayle et al., 1999). Like SERCA,
Pmr1p belongs to the type IIa family of P-type ATPases and
some phenotypes of 
 
pmr1
 
 
 
 mutants can be complemented
by expression of SERCA1a or related ATPases (Liang et al.,
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1997; Duerr et al., 1998; Talla et al., 1998; Degand et al.,
1999). Pmr1p has been shown to transport both calcium
and manganese, but how the Golgi apparatus–localized
Pmr1p supplies calcium to the ER is unclear (Mandal et al.,
2000; Wei et al., 2000).
We and others have recently identified another P-type
ATPase in yeast, Cod1p/Spf1p, that adds a new dimension to
the regulation of ER ion supply (Suzuki and Shimma, 1999;
Cronin et al., 2000). Cod1p belongs to the type V subfamily
of P-type ATPases that are broadly conserved in eukaryotes
but for which no ionic substrates have yet been identified
(Axelsen and Palmgren, 1998). Close homologues of Cod1p
are present in 
 
Drosophila melanogaster
 
, 
 
Caenorhabditis elegans
 
,
 
Dictyostelium discoideum
 
, 
 
Arabidopsis thaliana
 
, and humans
(Costanzo et al., 2000). Cod1p is the only member of the
type V subfamily for which any phenotypic information is
known. We identified 
 
COD1
 
 in a genetic screen for mutants
incapable of regulating the degradation of the ER membrane
protein Hmg2p (Cronin et al., 2000). The involvement of
Cod1p in the degradation of an ER protein as well as other
ER phenotypes implies that Cod1p functions in the ER (Su-
zuki and Shimma, 1999; Cronin et al., 2000). Furthermore,
the 
 
cod1
 
 mutant phenotype suggests a role for Cod1p in cal-
cium regulation because the mutant phenotype could be par-
tially suppressed by exogenous calcium (Cronin et al., 2000).
These observations led us to propose that Cod1p functions to
supply Ca
 
2
 
 
 
 to the ER (Cronin et al., 2000).
In this paper, we directly examined the role of Cod1p in
ER function and calcium regulation in vivo and the bio-
chemical requirements for Cod1p ATPase activity in vitro.
We have now demonstrated that Cod1p localized to the ER
by both immunofluorescence and subcellular fractionation,
and have provided phenotypic evidence supporting a role for
Cod1p in ER function and cellular calcium regulation. Fur-
ther, we have distinguished phenotypically the roles of
Cod1p and Pmr1p in ER function and quality control. Fi-
nally, we purified the Cod1 protein and directly demon-
strated the ATPase activity of Cod1p in vitro. Taken to-
gether, our data indicated that Cod1p plays a significant role
in ER function and cellular Ca
 
2
 
 
 
 homeostasis that is not
equivalent to, nor redundant with, the role of Pmr1p or
other P-type ATPases. Moreover, the presence of Cod1p ho-
mologues in the genomes of all sequenced metazoans sug-
gested that the function of Cod1p is likely to be more widely
conserved in eukaryotes than that of more restricted, but
better known, pumps such as the SERCA ATPases.
 
Results
 
Cod1p is localized to the ER
 
Many of the phenotypes of the 
 
cod1
 
 mutants suggested that
Cod1p functions in the ER (Suzuki and Shimma, 1999;
Cronin et al., 2000). Accordingly, we determined the local-
ization of Cod1p by both immunofluorescence microscopy
and density gradient fractionation (Fig. 1). To facilitate
localization, we constructed the 
 
3MYC::COD1
 
 allele of
 
COD1
 
 expressing a protein with three myc epitopes fused to
the amino terminus of the protein. 3myc–Cod1p was ex-
pressed from the unmodified 
 
COD1
 
 promoter in single
copy, preventing aberrant localization due to overexpression.
Figure 1. Cod1p is localized to the endoplasmic reticulum. 
Comparison of the distribution of 3myc–Cod1p with the 
distribution of the ER proteins Kar2p (A) and Sec61p (B) by 
immunofluorescence as described in the Materials and methods. 
Yeast lysates prepared in the presence of EDTA (C) or magnesium 
(D) were fractionated on a 10–60% linear sucrose gradient. 
Protein from each fraction was separated by SDS-PAGE, 
transferred to nitrocellulose, and probed with the appropriate 
antibodies. 
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Strains expressing 3myc–Cod1p are phenotypically wild
type in all ways tested (unpublished data). The pattern of
staining for 3myc–Cod1p was typical for ER localization,
with a distinct ring around the nucleus and additional stain-
ing near the cell periphery. The distribution of Cod1p,
though slightly more extensive, overlapped considerably
with the distribution of Kar2p, a protein residing in the lu-
men of the ER (Fig. 1 A) (Rose et al., 1989; Preuss et al.,
1991). We also saw the same pattern of perinuclear and pe-
ripheral staining with Sec61p, a component of the ER trans-
location apparatus (Fig. 1 B) (Stirling et al., 1992).
We independently tested the localization of 3myc–Cod1p
by fractionation of intracellular membranes on sucrose den-
sity gradients in the presence of EDTA or magnesium as de-
scribed in the Materials and methods (Fig. 1, C and D). A
characteristic of ER microsomes is that their buoyancy in a
sucrose gradient depends on the presence or absence of mag-
nesium in the gradient, allowing unambiguous assignment
of a membrane protein to the ER by testing the behavior of
the protein under both conditions (Roberg et al., 1997).
The distribution of 3myc–Cod1p in all gradients closely
overlapped the distribution of the ER-localized Sec61p.
When fractions were prepared with 2 mM MgCl
 
2
 
, the ER
containing 3myc–Cod1p and Sec61p cofractionated with
the plasma membrane marker Gas1p (Doering and Schek-
man, 1996) and separated from the Golgi apparatus–derived
membranes labeled by Emp47 (Schröder et al., 1995).
When fractions were prepared with EDTA, 3myc–Cod1p
and Sec61p cofractionated with Emp47p and separated
from Gas1p, thus confirming that the fractions containing
3myc–Cod1p were derived from the ER.
 
Deletion of Cod1p induced expression of 
calcium-regulated genes
 
Calcium concentration within the cytosol and secretory
pathway regulates the expression of a number of genes, and
mutations that perturb cellular calcium induce compensa-
tory changes in gene expression (Garrett-Engele et al., 1995;
Matheos et al., 1997; Locke et al., 2000). For instance, dele-
tion of 
 
PMR1
 
 produces a five- to sevenfold increase in the
transcription of 
 
PMC1
 
, a vacuolar calcium ATPase (Marchi
et al., 1999, Locke et al., 2000). We investigated the effect
of 
 
cod1
 
 deletion on the expression of 
 
FKS2
 
, 
 
PMC1
 
, and
 
ENA1,
 
 genes known to be regulated in response to calcium
concentration, using previously described 
 
 
 
-galactosidase re-
porter plasmids (Fig. 2, A and B) (Matheos et al., 1997;
Locke et al., 2000). The expression of each of the three cal-
cium-activated reporters was three- to sevenfold higher in
the 
 
cod1
 
 
 
 mutant than in wild-type cells grown under nor-
mal laboratory conditions and in the absence of any external
calcium stimulus. This effect of 
 
cod1
 
 
 
 was similar to that re-
ported earlier for 
 
pmr1
 
 
 
 (Locke et al., 2000). Importantly,
transient treatment with 200 mM CaCl
 
2
 
 induced 
 
 
 
-galac-
tosidase activity to the same level both in wild-type and
 
cod1
 
 
 
 cells, indicating that deletion of 
 
COD1
 
 did not inter-
fere with the ability of the reporter constructs to respond to
calcium stimulation (unpublished data). Likewise, treatment
of cultures with the calcineurin inhibitor cyclosporin A di-
minished expression of the reporter genes, indicating that
the increased expression in 
 
cod1
 
 
 
 was largely calceneurin de-
pendent (Fig. 2 B; unpublished data). A portion of the in-
crease may be calcineurin independent, as the treatment did
not reduce expression to the same level as in wild type. The
increased 
 
 
 
-galactosidase activity in the 
 
cod1
 
 
 
 mutants was
specific to the calcium-regulated reporters. Expression of the
 
CYC1–
 
 
 
-galactosidase reporter, which is not responsive to
calcium (Matheos et al., 1997), did not differ significantly
between wild-type and 
 
cod1
 
 
 
 strains (Fig. 2 A).
 
cod1
 
 
 
 mutants are specifically hypersensitive to 
extracellular calcium
 
Hypersensitivity to an extracellular ion can indicate a defect
in intracellular transport of that ion. For example, mutants
defective in the calcium and manganese pump Pmr1p are hy-
persensitive to the presence of calcium and manganese in the
growth medium (Lapinskas et al., 1995; Wei et al., 2000)
(Fig. 3 A). Thus, we tested the ability of the 
 
cod1
 
 
 
 null mu-
tant to grow in high levels of extracellular calcium or other
cations. We found that 
 
cod1
 
 
 
 mutants had over twice the
sensitivity to calcium as wild-type cells, sensitivity equivalent
to that of 
 
pmr1
 
 
 
 mutants. The combined deletion of both
 
cod1
 
 and 
 
pmr1
 
 further increased sensitivity to extracellular
calcium to four times that of wild-type cells. The defect was
specific to calcium, as 
 
cod1
 
 
 
 mutants were no more sensitive
to other divalent ions than wild-type cells (unpublished
data). For example, deletion of 
 
COD1
 
 did not affect manga-
nese sensitivity, which was greatly increased in 
 
pmr1
 
 
 
 strains,
and the hypersensitivity of a 
 
pmr1
 
 
 
 null mutant to manga-
nese was not further exacerbated by a 
 
cod1
 
 
 
 allele (Fig. 3 A)
 
.
 
Role of Cod1p in maintaining total cellular calcium level
 
The increase in expression of calcium-regulated genes and
hypersensitivity to calcium suggested that Cod1p might in-
fluence total cellular ion content under some conditions. For
example, deletion of 
 
PMR1
 
 results in increased cellular cal-
cium and increased cellular manganese (Lapinskas et al.,
1995) (Fig. 3 B). We examined the level of a number of ions
in wild-type and 
 
cod1
 
 
 
 cultures by inductively coupled
Figure 2. Expression of calcium-responsive genes 
is induced in cod1 . (A) Log phase cultures of 
wild-type (RHY1708) and cod1  cells (RHY1709) 
expressing  -galactosidase reporters were grown 
in YPD and assayed for  -galactosidase activity as 
described in the Materials and methods. (B) Log 
phase cultures of wild-type and cod1  cells were 
grown overnight in the presence or absence of 
30  g/ml of cyclosporin A and assayed for 
 -galactosidase activity. Representative experiments 
are shown. 
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plasma optical emission spectrometry (ICP-OES) as de-
scribed in the Materials and methods (Fig. 3 B). Deletion of
 
COD1
 
 alone did not affect cellular calcium levels. However,
deletion of both 
 
COD1
 
 and 
 
PMR1
 
 produced a synergistic
increase in intracellular calcium compared with 
 
cod1
 
 
 
 or
 
pmr1
 
 
 
 alone. This synergistic effect was specific to calcium:
although 
 
pmr1
 
 
 
 cells also displayed increased manganese
levels, the combined deletion of 
 
cod1
 
 and 
 
pmr1
 
 did not fur-
ther increase total cellular manganese (Fig. 3 B). Deletion of
 
COD1
 
 either alone or in the presence of 
 
pmr1
 
 
 
 had no ef-
fect on the total cellular concentration of magnesium, iron,
zinc, copper, or any other ion detected in yeast cultures,
demonstrating that the effect of 
 
cod1
 
 
 
 was specific.
 
Cod1p is necessary for normal ER function
 
The localization of Cod1p to the ER and the previously re-
ported phenotypes of the 
 
cod1
 
 mutants suggested that Cod1p
plays a major role in the function of the ER. We tested the sen-
sitivity of 
 
cod
 
 mutants to the reducing agent DTT and the gly-
cosylation inhibitor tunicamycin, both of which (through dis-
tinct mechanisms) alter protein folding in the ER (Fig. 4 A).
 
cod1-1
 
 cells had twice the sensitivity to tunicamycin as wild-
type cells, but maintained normal sensitivity to DTT. Treat-
ment of wild-type cells with either agent provokes the accumu-
lation of unfolded proteins in the ER, inducing the unfolded
protein response (UPR) (Frand and Kaiser, 1998; Pollard et al.,
1998). We measured the unfolded protein response with a
UPR reporter plasmid (4xUPRE–green fluorescent protein
[GFP]) consisting of four unfolded protein response elements
driving expression of the GFP coding region (4xUPRE; Fig. 4
B; Pollard et al., 1998). Strikingly, the GFP reporter in the
 
cod1
 
 
 
 mutant was constitutively expressed at 10 times the level
of expression in wild-type cells in the absence of any additional
stimulus. Furthermore, in cod1 , maximum expression of the
UPR reporter required only half the dose of tunicamycin (2  g/
ml) needed to stimulate maximum expression in wild-type cells.
As expected from the growth sensitivity experiments, the cod1 
mutant displayed wild-type sensitivity to DTT in the unfolded
Figure 4. Deletion of COD1 produces phenotypes indicating the 
presence of misfolded proteins in the ER. (A) Growth arrest of 
wild-type (RHY791) and cod1-1 (RHY811) cells by tunicamycin or 
DTT. Low-density cultures (OD600   0.01) were grown in minimal 
medium in the presence of the indicated concentrations of added 
tunicamycin or DTT. Growth is plotted as a percentage of the 
outgrowth of the untreated culture. (B) Wild-type (RHY1708) and 
cod1  (RHY1709) cells transformed with a plasmid expressing GFP 
from four unfolded protein response elements were treated for 4 h 
with the indicated concentrations of tunicamycin or DTT and analyzed 
by flow microfluorimetry. Each histogram represents 10,000 cells. 
(C) cod1-1 null mutants (RHY910) were mated to hac1  mutants 
(RHY1664). The diploids were sporulated and dissected on YPD 
plates. (D) Wild-type, hac1 , pmr1 , and hac1 /pmr1  cells 
(MYY290, RHY1884, RHY2179, and RHY2277) were streaked onto 
minimal media lacking inositol or containing 20 mM EGTA.
Figure 3. cod1  display phenotypes specific to calcium but not to 
manganese. (A) Growth arrest of wild-type, cod1 , pmr1 , and 
cod1 /pmr1  cells (CS601A, CS601B, CS601C, and CS601D) by 
CaCl2 or MnCl2. Low-density cultures (OD600   .01) were grown in 
liquid YPD, pH 5.5, in the presence of the indicated concentrations 
of added CaCl2 or MnCl2 for 2.5 d. Growth is plotted as a percentage 
of the outgrowth of the untreated culture. (B) Deletion of PMR1 and 
COD1 causes a synergistic increase in total cellular calcium, but 
not manganese. Cultures were grown overnight in YPD, pH 5.5, to 
an optical density of approximately one and then processed as 
described in the Materials and methods. Representative experiments 
are shown. Cod1p and ER function | Cronin et al. 1021
protein response. Maximal induction of the reporter protein re-
quired 2 mM DTT in both wild-type and cod1 .
Inactivation of the UPR is synthetically lethal in a 
cod1 null
The unfolded protein response is mediated by the transcrip-
tion factor Hac1p (Cox and Walter, 1996; Nikawa et al.,
1996). We tested the necessity of the UPR in the cod1 mutant
by crossing a cod1-1 null mutant to a hac1  mutant (Fig. 4 C).
Sporulation of the diploid and dissection of 22 of the resulting
ascospores revealed the synthetic lethality of hac1  cod1-1
double mutants. We confirmed this result using cod1 ::Kan
R
and hac1 ::URA3 alleles. In 19 tetrads, no colonies with the
Ura
 , Kan
R phenotype were observed. We obtained identical
results using cod1 ::HIS3 and hac1 ::URA3 null alleles in the
unrelated MYY290 genetic background (14 tetrads analyzed).
Microcolonies, three to five cells in diameter, were seen by mi-
croscopy on the dissection plate, but these did not grow further
even after prolonged incubation. The presence of the microcol-
onies indicated that the cod1 , hac1  spores were capable of
germinating but incapable of sustained growth. In contrast,
double mutants of hac1 and YOR291w, the closest yeast ho-
mologue to COD1, were viable (unpublished data).
pmr1 mutants have phenotypes indicative of a perturbed
UPR, including hypersensitivity to DTT and tunicamycin,
inositol auxotrophy, and increased expression of the ER chap-
erone Kar2p (Duerr et al., 1998). We examined the viability
of a pmr1  hac1  double mutant in the same genetic back-
ground in which cod1  hac1  cells were inviable (Fig. 4 D).
Surprisingly, the pmr1  hac1  double mutants were viable.
The  pmr1  hac1  double mutant retained phenotypes of
both parent strains: hypersensitivity to EGTA (pmr1 ) and
inositol auxotrophy (hac1 ). The cod1  mutant was pro-
totrophic for inositol in all strains tested (unpublished data).
Thus, although Cod1p and Pmr1p had synthetic effects on
whole cell calcium that implied shared functions, they also
clearly had distinct, nonoverlapping ER functions.
Regulated degradation of Hmg2p does not require 
the UPR
The constitutive activation of the UPR and the constitutive
degradation of Hmg2p in the cod1  mutant raised the possibil-
ity that UPR played a role in regulating Hmg2p degradation
(cod1  mutants cannot regulate the degradation of Hmg2p
(Cronin et al., 2000). In wild-type cells, treatment with lova-
statin (a 3-hydroxy-3-methylglutaryl coenzyme A reductase
[HMGR] inhibitor) slows Hmg2p degradation and raises
Hmg2p levels (Hampton and Rine, 1994). This regulation can
be measured by flow cytometry using the Hmg2p–GFP re-
porter protein (Hampton et al., 1996; Gardner and Hampton,
1999). We tested the effect of UPR activation on the regulated
degradation of the Hmg2p–GFP by treatment with the glyco-
sylation inhibitor tunicamycin (Fig. 5 A). Hmg2p–GFP degra-
dation in cells treated with 4  g/ml tunicamycin (a dose that
fully induces the UPR) still responded to treatment with lova-
statin in the same manner as cells grown without tunicamycin.
In fact, Hmg2p–GFP degradation was moderately slowed by
tunicamycin treatment. Thus, the unregulated, constitutive
degradation of Hmg2p present in cod1 mutants cannot be at-
tributed to activation of the unfolded protein response or to de-
fective glycosylation. We deleted HAC1 to determine if the un-
folded protein response was required for regulation of Hmg2p
degradation (Fig. 5 B). The regulated degradation of Hmg2p–
GFP in hac1  cells treated with lovastatin was indistinguishable
from that seen in wild-type cells under the same treatment de-
spite reports that some degradation substrates require the UPR
for ER-associated degradation.
The role of Cod1p is functionally conserved between 
yeast and D. melanogaster
Genes closely homologous to COD1 have been identified in
several metazoans including humans. These putative ortho-
logues are more similar to COD1 than COD1 is to its closest
yeast homologue, YOR291w. For example, D. melanogaster ex-
presses a gene GH06032, which we refer to as dCOD1, with
40% identity and 58% similarity in the protein sequence to
Cod1p (Costanzo et al., 2000). We constructed a modified ver-
sion of dCOD1 for expression in yeast, encoding dCod1p with
a hemagglutinin (HA) epitope tag fused to the amino terminus.
We expressed HA–dCod1p from several different promoters in
the cod1  mutant to test its ability to complement the mutant
phenotype. cod1  mutants cannot regulate the degradation of
the HMGR isozyme Hmg2p (Cronin et al., 2000) (Fig. 6).
This defect in the regulated degradation of Hmg2p causes
cod1  mutants to be hypersensitive to the HMGR inhibitor
lovastatin in the appropriate genetic background. Expression of
dCOD1 from the strong TDH3 or PMA1 promoters rescued
growth of cod1  mutants on lovastatin, whereas expression of
dCOD1 from the weaker COD1 promoter was not sufficient to
restore lovastatin resistance (Fig. 6). As expected from the rever-
sal of drug sensitivity, dCOD1 also restored regulation of
Hmg2p degradation, as measured by flow cytometry using the
Hmg2p–GFP reporter protein (Fig. 6 B).
Complementation of cod1  phenotypes was specific for
P-type ATPases closely related to Cod1p. We tested the abil-
Figure 5. Glycosylation and the UPR are not required for regulating 
Hmg2p–GFP degradation. (A) Tunicamycin does not affect the 
stabilization of Hmg2p–GFP by lovastatin. Early log phase cultures 
were grown for 4 h in 4  g/ml tunicamycin and the presence or 
absence of 25  g/ml lovastatin and subjected to flow cytometry. 
(B) Hmg2p–GFP regulation does not require HAC1. Early log phase 
cultures of wild-type (RHY872) or HAC1  (RHY1664) cells were 
grown for 4 h in the presence or absence of 25  g/ml lovastatin and 
subjected to flow cytometry.1022 The Journal of Cell Biology | Volume 157, Number 6, 2002
ity of the type IIa P-type ATPases SERCA1a and ACA3
(from A. thaliana) to complement the cod1 mutant pheno-
type with respect to Hmg2p–GFP degradation. Both of
these genes complement the pmr1 mutant phenotype, but
neither could complement the cod1 mutant phenotype, nor
could overexpression of PMR1 (Fig. 6 B; unpublished data).
Similarly, overexpression of HA::COD1 or HA::dCOD1
could not complement the sensitivity of pmr1  mutants to
EGTA, suggesting that the roles of Cod1p and Pmr1p in ER
function do not overlap significantly (unpublished data).
The lack of cross-complementation also raises the possibility
that the similar effects of pmr1 and cod1 on total cellular cal-
cium may arise through different mechanisms.
Biochemical characterization of Cod1p
To directly study the biochemistry of Cod1p, we constructed a
gene that expressed a modified version of the Cod1 protein
with nine histidine residues and an HA epitope tag inserted just
after the amino-terminal methionine. The plasmid comple-
mented the cod1  mutant phenotype (Fig. 7). Cells expressing
the histidine-tagged Cod1 protein from the native COD1 pro-
moter at single copy or the much stronger TDH3 promoter
from a 2  plasmid were wild type for regulating Hmg2p–GFP
degradation (Fig. 7; unpublished data). We also constructed a
derivative of this plasmid expressing the mutant D487N-
Cod1p. In this mutant protein, the aspartyl phosphorylation
site strictly conserved in all P-type ATPases was replaced by an
asparagine residue. The plasmid expressing the D487N-Cod1p
was unable to complement the cod1  null phenotype as ex-
pected from previous studies (Fig. 7; Suzuki, 2001).
We purified wild-type histidine-tagged Cod1p and the
nonfunctional D487N protein using nickel affinity chroma-
tography as described in detail in the Materials and methods
section (Fig. 8, A and B). The purification yielded a single
major band corresponding to the tagged Cod1p. Minor
products detected in the elutions were the same in the puri-
fications of both wild-type and the D487N mutant proteins.
We tested the purified proteins for the ability to hydrolyze
ATP using a sensitive radiochemical assay described previ-
ously (Bais, 1975; Ghosh et al., 1990; Mandal et al., 2000).
The assay measures the free inorganic phosphate produced
from [ 
32-P]ATP, taking advantage of the fact that activated
charcoal will sequester unhydrolyzed ATP but not the liber-
ated 
32Pi. Wild-type Cod1p hydrolyzed ATP in a time-
dependent manner, with free phosphate increasing linearly
with time (Fig. 8 C). In contrast, the mutant D487N pro-
tein produced no detectable ATPase activity (Fig. 8 C). The
reaction catalyzed by the eluted Cod1p was dependent on
the concentration of ATP and could be modeled using
Michaelis-Menten kinetics (Fig. 8 D). In the presence of 5
mM magnesium, Cod1p exhibited a Km of  15  M for
ATP hydrolysis and a Vmax of  150 nmol Pi/min/mg. As
with other P-type ATPases, the activity of Cod1p was inhib-
ited by 500  M vanadate (unpublished data).
It has previously been demonstrated that the ATPase activity
of P-type pumps can be stimulated by the presence of its ionic
substrates. Thus, stimulation of ATPase activity by an ion nor-
mally indicates that the ion is transported by the ATPase. For
example, the ATPase activity of the Golgi apparatus–localized
Pmr1p is stimulated with calcium and manganese, the sub-
strates it transports (Mandal et al., 2000). Accordingly, we
tested calcium to see if it would stimulate the ATPase activity of
Cod1p (Fig. 9, A and B). Surprisingly, calcium failed to in-
crease the ATPase activity of Cod1p. In fact, higher concentra-
tions of calcium ( 10  M free calcium) inhibited the activity
of Cod1p (Fig. 9, A and B). We next tested various biologically
relevant cations with the aim of identifying which ion was the
substrate of Cod1p. The range of ions tested included Ca
2 ,
Sr
2 , Ba
2 , Mn
2 , Fe
2 , Fe
3 , Co
2 , Ni
2 , Cu
2 , Zn
2 , and
Cd
2 , none of which stimulated activity above the level seen
Figure 6. Functional conservation of Cod1 between S. cerevisiae 
and D. melanogaster. (A) Lovastatin sensitivity of cod1  cells 
(RHY1401) transformed with a high copy plasmid expressing nothing, 
PTDH3-HA::COD1, or PTDH3-HA::dCOD1. Cultures were streaked 
onto plates containing 200  g/ml lovastatin and incubated at 30 C. 
(B) Regulation of Hmg2p–GFP degradation in cod1-1 cells 
(RHY911) expressing the indicated P-type ATPases expressed from 
the PMA1 promoter. Early log phase cultures were grown for 4 h in 
the presence or absence of 25  g/ml lovastatin and subjected to 
flow cytometry.
Figure 7. The D487N mutation inactivates Cod1p. Regulation of 
Hmg2p–GFP in cod1  cells (RHY2681) transformed with a plasmid 
expressing PTDH3-9HIS–HA–COD1 (COD1) or PTDH3-9HIS–HA–COD1 
with the D487N mutation (D487N). Lovastatin was added at 25  g/ml 
and cultures were grown at 30 C for 4 h after the addition of lovastatin. Cod1p and ER function | Cronin et al. 1023
with magnesium alone (Fig. 9, A and B; unpublished data). Re-
placing the K
  in the assays with Li
 , Na
 , Rb
 , or Cs
  did
not affect the activity of the protein (unpublished data). To en-
sure that trace amounts of any possible contaminating cations
were not stimulating the activity of Cod1p, we assayed the
ATPase activity in the presence of increasing concentrations of
the chelators TPEN, 1,10-phenanthroline, and EDTA (Fig. 9
C). TPEN and 1,10-phenanthroline have been used to remove
metals such as zinc from metalloenzymes (Arslan et al., 1985;
Dawson et al., 1986; Bays et al., 2001). None of the chelators
diminished the activity of Cod1p; rather, the chelating agents
all stimulated the activity of the enzyme, suggesting that heavy
metals may inhibit the activity of the enzyme. The only ion for
which Cod1p showed any dependence was Mg
2 .
Mg
2  in the form of an MgATP complex is required for all
characterized P-type ATPases. Studies of other P-type ATPases
have shown a requirement for additional free Mg
2  in order to
obtain maximal activity (Skou, 1974; Ahlers, 1981; Plesner and
Plesner, 1981; Brooker and Slayman, 1983). In these studies,
maximal stimulation of the ATPase was usually observed when
the total concentration of magnesium was one to three times
the total concentration of ATP. We investigated the depen-
dence of Cod1p on Mg
2  by varying the concentration of
added MgCl2 while keeping a total ATP concentration of 50
 M (Fig. 9, D and E). Because of the large excess of Mg
2  rela-
tive to the concentration of ATP, the MgATP concentration
was nearly constant above 1.25 mM. Cod1p activity increased
up to 10 mM Mg
2 , after which it began to decline slowly (Fig.
Figure 8. Purification and ATPase activity of wild-type and 
D487N versions of 9HIS–HA–Cod1p. (A) SDS-PAGE stained with 
Gelcode blue. (B) Western blots with anti-HA antibodies. (C) 0.015 
 g of histidine-tagged Cod1p ( ), D487N ( ), or nothing ( ) were 
incubated in 50 mM Hepes/TRIS, 100 mM KCl, 5 mM MgCl2, 1 mM 
EDTA, and 50  M  
32-labeled ATP for the indicated times. 
(D) 0.015  g of histidine-tagged Cod1p ( ) was incubated for 5 min 
in 50 mM Hepes/TRIS, 100 mM KCl, 5 mM MgCl2, 1 mM EDTA, 
and the indicated amounts of  
32-labeled ATP. Representative 
experiments are shown.
Figure 9. Effect of ions on Cod1p. (A) 0.135  g of histidine-tagged 
Cod1p was incubated in 1 mM EDTA, 50 mM Hepes/TRIS, 100 mM 
KCl, 10 mM MgCl2, 50  M [ 
32]ATP, and increasing amounts of 
CaCl2, MnCl2, or CuSO4. Experiments with CuSO4 were done 
without EDTA. Results are plotted with respect to the calculated free 
concentration of the indicated ion. (B) 0.15  g of histidine-tagged 
Cod1p was incubated in 50 mM Hepes/TRIS, 100 mM KCl, 5 mM 
MgCl2, and 50  M  
32-labeled ATP for 5 min with the addition of 
100  M of the indicated ions, or nothing. (C) 0.15  g of Cod1p was 
incubated in 50 mM Hepes/TRIS, 100 mM KCl, 5 mM MgCl2, and 
50  M  
32-labeled ATP for 5 min in the presence of the indicated 
concentrations of TPEN, 1,10-phenanthroline (Phen), or EDTA. 
(D) 0.015  g of Cod1p was incubated for 5 min in 50 mM Hepes/
TRIS, 100 mM KCl, 1 mM EDTA, 50  M  
32-labeled ATP, and 
increasing concentrations of MgCl2. The ATPase activity of Cod1p 
( ) is plotted with respect to the concentration of free Mg
2  on the 
primary y axis. The calculated concentration of MgATP with respect 
to the concentration of free Mg
2  is plotted as a dotted line on the 
secondary y axis. (E) The same data as in D, plotted on the primary 
y axis with respect to the calculated concentration of MgATP. The 
calculated concentration of free Mg
2  is plotted with respect to the 
calculated concentration of MgATP as a dotted line. Representative 
experiments are shown.1024 The Journal of Cell Biology | Volume 157, Number 6, 2002
9, D and E; unpublished data). The increase in Cod1p activity
between 1.25 and 10 mM indicated a dependence on free
Mg
2 , because in this range, the concentration of MgATP re-
mained constant. However, the increase in total activity due to
free magnesium was on the order of twofold at maximum.
Discussion
The regulation of ions in the ER is of central importance to
the cell, given the numerous functions of this organelle.
However, the only known supplier of ions to the ER was the
Golgi apparatus–localized Pmr1p, which has been shown to
influence the concentration of calcium in the ER (Strayle et
al., 1999). Our previous work and that of others raised the
possibility that Cod1p might play an important role with re-
gard to ER ion regulation (Suzuki and Shimma, 1999; Cro-
nin et al., 2000). In this work, we show that Cod1p is local-
ized to, and centrally involved in, the function of the ER
and in calcium regulation, and demonstrate the biochemi-
cal activity of Cod1p. Our cross-complementation studies,
along with the broad conservation of Cod1p among meta-
zoans, indicate that Cod1p shares similar functions in a
broad range of organisms. Thus, it appears that Cod1p and
its orthologues play a unique role in the functioning of the
ER, quite distinct from other known P-type ATPases.
Our studies clearly show that Cod1p is a functionally im-
portant ER protein. Unique among yeast P-type ATPases,
Cod1p localized to the ER membrane, as measured by im-
munofluorescence and direct biochemical analysis. The
Cod1p subcellular localization is consistent with the func-
tions and phenotypes of this ion pump. Our study and other
studies had previously demonstrated phenotypes in ER-asso-
ciated processes such as N-linked glycosylation and regula-
tion of HMGR stability (Suzuki and Shimma, 1999; Cronin
et al., 2000). The experiments above showed that Cod1p
was critical in maintaining the proper ER folding environ-
ment and was required for viability of mutants deficient in
the UPR, presumably due to its role in maintaining ER ion
balance, as discussed below. Furthermore, at least in our
strains, Cod1p had a more important role in this regard than
Pmr1p, because the same synthetic lethality with hac1  was
not observed with a pmr1  null. Taken together, our local-
ization and phenotypic studies showed Cod1p to be a criti-
cal and conserved participant in ER function, with numer-
ous phenotypes that arise from its action on ER physiology.
The identity of Cod1p as a P-type ATPase and its impor-
tance in the normal functioning of the ER suggests that it
functions to control the balance of one or more ions in the lu-
men of the ER. The idea that this ion might be calcium first
arose from our previous observations of cod1 suppression by
manipulating exogenous calcium (Cronin et al., 2000). In this
work, we further examined the role of Cod1p in calcium
maintenance in a variety of ways. Increased expression of
calcineurin-related genes can indicate depletion of secretory
pathway calcium store, and a cod1  null showed the ex-
pected increase in expression of the calcineurin-activated genes
PMC1, ENA1, and FKS2 (Cunningham and Fink, 1996; Ma-
theos et al., 1997). In this assay, it is interesting to note that the
magnitude of the effect of COD1 inactivation was similar to
that reported for pmr1  nulls (Locke et al., 2000). Similarly,
the specific growth hypersensitivity of cod1  strains to calcium
chloride is reminiscent of the growth sensitivities of mutants
lacking calcium-specific P-type ATPases. For example, dele-
tion of the vacuolar calcium ATPase PMC1 results in calcium
hypersensitivity, and deletion of the Golgi apparatus ATPase
PMR1 leads to calcium and manganese hypersensitivity (Cun-
ningham and Fink, 1994a; Lapinskas et al., 1996; Wei et al.,
2000). Finally, the synergistic effect of cod1  and pmr1  on
total cellular calcium, but no other ions, also pointed to a role
for COD1 in maintaining cellular calcium homeostasis.
Although the calcium-related phenotypes were suggestive of
direct involvement in calcium transport, our cross-comple-
mentation experiments and biochemical data suggested that
Cod1p may influence the ER in a different manner. The
known Ca
2 _transporting ATPases group together by se-
quence homology (type II) and are generally capable of substi-
tuting for each other’s function in vivo. This property has
been used extensively to clone new Ca
2  pumps and aid in the
characterization of Ca
2  specificity of pumps cloned by other
means (Liang et al., 1997; Harper et al., 1998; Talla et al.,
1998; Degand et al., 1999). For example, SERCA1a from rab-
bit,  ECA1 from A.  thaliana, and SMA1 from Schistosoma
mansoni all restore some functions to yeast mutants lacking
the genes encoding the endogenous Ca
2  pumps Pmr1p and
Pmc1p (Liang et al., 1997; Talla et al., 1998; Degand et al.,
1999). It should be noted that the ability of exogenous pumps
to complement yeast mutants does not strictly depend on the
localization of the exogenous pump. Thus, functions of the
Golgi apparatus–localized Pmr1p and the vacuolar Pmc1p
can be substituted by the exogenous SERCA1 pump localized
to the ER in yeast (Degand et al., 1999). In contrast to the ap-
parent facility with which these pumps replace each other,
neither SERCA nor ACA2, nor overexpressed PMR1, could
suppress phenotypic defects of the cod1  null mutant. Simi-
larly, overexpression of Cod1p did not suppress the EGTA
sensitivity of pmr1 . Thus, if Cod1p contributes to the ER by
directly pumping calcium, it must be doing so in a manner
distinct from the previously known type II calcium pumps.
To further examine whether or not Cod1p was directly in-
volved in calcium transport, we purified the Cod1 protein to
identify the biochemical requirements for Cod1p ATPase ac-
tivity in vitro. P-type ATPases exhibit enhanced activity in
the presence of their substrates, such that the ATPase activity
of SERCA1 is stimulated by calcium, the sodium/potassium
ATPase by sodium and potassium (Koenderink et al., 2000),
Pmr1p by manganese and calcium (Mandal et al., 2000), and
the Menkes protein by copper (Voskoboinik et al., 2001).
Surprisingly, calcium was not required for the biochemical
activity of Cod1p, and at higher concentrations ( 100  M),
Ca
2  inhibited activity. In fact, in the apparent absence of
any substrate, Cod1p hydrolyzed ATP at a rate similar to that
of other P-type ATPases. For example, Pmr1 has a Vmax of
near 200 nmol Pi/min/mg in the presence of its preferred
substrates Ca
2  and Mn
2  (Mandal et al., 2000), whereas
Cod1p exhibits a Vmax for ATP hydrolysis of  150 nmol
Pi/min/mg in reactions containing solely the eluted product,
magnesium, potassium, and micromolar quantities of so-
dium. The metal chelators EDTA, TPEN, and 1,10-phenan-
throline each activated (or de-inhibited?) Cod1p activity
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the free concentration of any divalent ions in the assay with
the exception of magnesium. Cod1p appears to be acting
quite differently from known P-type pumps.
A possible explanation is that the in vitro ATPase activity
demonstrated by Cod1p is simply uncoupled from pumping
activity. This might occur if the factors coupling Cod1p to a
specific ion or ions were lost during the purification of the
enzyme. This model suggests that the inability of the Dro-
sophila homologue of Cod1p to complement the cod  mutant
at low copy was due to poor interaction of dCod1p with the
required factors in yeast. A requirement for specificity-deter-
mining factors also leaves open the possibility for a direct role
for Cod1p in calcium transport. Such coupling factors would
be quite unexpected. The ATPase activity of some pumps bas
been uncoupled from transport by cis mutations, and several
mammalian P-type ATPases have   subunits. However none
of the   subunits appear to modify the substrate specificity
of the enzyme. Additionally, although we have been able
to measure calcium transport by Pmr1p, Pmc1p, rabbit
SERCA, and other Ca
2 -specific ATPases in yeast mi-
crosomes (Sorin et al., 1997; Marchi et al., 1999; Ton et al.,
2002), we have been unable to detect calcium transport by
Cod1p-containing microsomes (unpublished data).
Another possibility is that magnesium is a substrate for
Cod1p. P-type ATPases in general need free magnesium in
order to hydrolyze ATP. The concentration of free magne-
sium needed for activation depends on the concentration of
ATP present, such that generally the ratio of magnesium to
ATP needed falls within the range of 1–3 mol magnesium
per mol ATP (Ahlers, 1981; Plesner and Plesner, 1981;
Brooker and Slayman, 1983; Skou, 1974). In the case of
Cod1p, we obtained the greatest activity at a relatively high
concentration of 10 mM magnesium, a concentration 200
times the concentration of ATP in the assay mix. A role for
Cod1p in Mg
2  is attractive given the biological importance
of magnesium. At present, magnesium supply and regulation
in yeast are poorly understood and information about the in-
tracellular distribution of magnesium is scarce (Beeler et al.,
1997). ATPases in the lumen of the ER, such as Kar2, and
other enzymes within the secretory pathway would presum-
ably need magnesium in the lumen. It would seem fitting
that yeast cells would have a way to transport magnesium
into the lumen of the ER. Although the high level of magne-
sium needed for the activity of Cod1p does not demonstrate
that Cod1p pumps magnesium, it suggests magnesium may
be a good starting point for further biochemical study.
A third possibility is that Cod1p transports nonmetallic sub-
strate. Recently, several groups have gathered evidence that the
type IV group of P-type ATPases are involved in the transloca-
tion of aminophospholipids necessary for the maintenance of
membrane lipid asymmetry (Tang et al., 1996; Chen et al.,
1999; Ding et al., 2000; Gomes et al., 2000), though this idea
has been challenged (Siegmund et al., 1998; Marx et al., 1999).
The type IV ATPases that have been studied, including the
Golgi apparatus–localized yeast protein Drs2p, are apparently
specific for phosphatidylserine. Yeast lacking DRS2 are defec-
tive in translocating a fluorescently labeled phosphatidylserine,
a defect that can be complemented by expression of the A.
thaliana ALA1, and the ATPase activity of bovine ATPase II is
stimulated by phosphatidylserine (Tang et al., 1996; Ding et
al., 2000; Gomes et al., 2000). Although the type V pumps,
such as Cod1p, are most homologous to Ca
2 -transporting
ATPases, when the sequence comparisons are restricted to cer-
tain core domains, the type V pumps are more similar to the
type IV ATPases than to other members of the P-type ATPase
family (Axelsen and Palmgren, 1998, 2001). The similar fea-
tures of core domain sequences between the type IV and V
groups suggest that an investigation of nonmetallic substrates
for Cod1p may be fruitful.
Understanding the role of Cod1p has significance for the un-
derstanding of the possible functions of the other type V ATP-
ases. Genes predicted to encode type V ATPases are present in
all of the eukaryotic genomes that have been sequenced to date,
yet none of the other members of the type V family are known
other than by sequence homology. A number of genes have
been identified, including one in humans, which are predicted
to encode proteins with a high degree of homology to Cod1p
( 35% identity and 55% similarity; Costanzo et al., 2000).
Our demonstration that one of these, the D.  melanogaster
dCod1p, rescues the cod1  mutant phenotype indicated exper-
imentally that the function of these proteins is conserved and
these proteins are orthologous to Cod1p. More distant homo-
logues of COD1 in the type V subgroup are even lesser known
and likely have other functions. YOR291w, the second yeast
type V ATPase has less homology to COD1 than dCOD1
(Costanzo et al., 2000). Deletion of YOR291w produces none
of the phenotypes displayed by cod1  mutants (this paper;
Cronin et al., 2000). In fact, we have been unable to detect any
phenotypes associated with this gene (unpublished data). Thus,
the degree of sequence similarity (or disparity) to Cod1p ap-
pears to be a useful predictor of function.
In conclusion, we have greatly extended the phenotypic
characterization of Cod1p, defining its role in calcium regu-
lation and ER function, and we have provided the first bio-
chemical exploration of Cod1p. This study provides the
foundation for further biochemical studies of Cod1p that
will likely illuminate the obscurity surrounding ion regula-
tion and enhance our understanding of the widely con-
served, yet little known, type V group of P-type ATPases.
Materials and methods
Materials
Restriction enzymes, Vent DNA polymerase, and T4 DNA ligase were ob-
tained from New England Biolabs, Inc. The 9E10 cell culture supernatant was
produced in our lab from cells (American Type Culture Collection accession
no. CRL 1729) grown in RPMI1640 culture medium (Life Technologies) with
10% FCS and supplements. HA.11 anti-HA antibody was obtained from
BAbCo. CY5-conjugated anti–rabbit antibody was a gift from Dr. Kit Pogliano
(UCSD). Affinity-purified HRP-conjugated goat anti–mouse antibodies were
purchased from Sigma-Aldrich. ECL chemiluminescence immunodetection re-
agents were from Amersham Pharmacia Biotech. Escherichia coli total lipid
extract was obtained from Avanti Polar Lipids, Inc. All other chemical reagents
were obtained from Sigma-Aldrich or Fisher Scientific.
Plasmid construction
pRH1112 (CEN, LEU2, HA::COD1) was constructed from pRH810 by us-
ing synthetic overlap extension to add sequence coding for an HA epitope
tag to the 5  end of COD1, just after the start codon. pRH1312 was con-
structed from pRH1112 by replacing the native promoter of COD1 be-
tween SacI and SphI sites with a PCR-amplified TDH3 (glyceraldehyde
3-phosphate dehydrogenase) promoter.
Plasmid pOT2-GH06032 containing the dCOD1 cDNA was purchased
from Research Genetics. pRH1388 (CEN, LEU2, HA::dCOD1) expressing
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oRH1328 and oRH1329 were used to amplify the proximal part of the
dCOD1 ORF before the AgeI site, adding sequence coding for an HA tag
just after the start codon. This PCR product was cut with AatII and AgeI and
ligated with the BglII–AatII fragment of pRH1112 and the AgeI–BglII frag-
ment of pOT2-GH06032. The HA–dCOD1 ORF was subsequently trans-
ferred to a number of plasmids including pRH1389 (2  LEU2 PTDH3-HA::
dCOD1) pRH1431 (2  URA3 PPMA1-HA::dCOd1) using AatII and BglII.
pRH1432 expressed 9HIS–HA–Cod1p from the TDH3 promoter on a high
copy plasmid. Synthetic overlap extension was used to add sequence coding
for nine histidine residues to the 5  end of PTDH3-HA::COD1, just after the start
codon and before the sequence coding for the HA epitope tag. Oligonucle-
otide primers oRH1079, oRH1082, oRH1354, and oRH1355 were used to
amplify from the template plasmid pRH1331 (2 , LEU2, PTDH3-HA::COD1).
The resulting PCR product was subcloned into pRH1332 (2 , URA3), using
BsiWI and EagI to yield pRH1432. Plasmid pRH1478 expressed the D487N
mutant of 9HIS–HA–Cod1p from the TDH3 promoter. It was constructed by
removing the BstEII–BstEII fragment coding for the D487N mutation from
pCS210 and placing it into the same sites of pRH1432.
Yeast culture and strains
Yeast strains were grown in minimal media (yeast nitrogen base without
amino acids; Difco) with glucose and the appropriate supplements as de-
scribed previously, except that leucine supplementation was increased to
60 mg/liter. Experiments were performed in minimal media at 30 C unless
otherwise noted. For protein purification, yeast strains were grown in min-
imal media with glucose supplemented with 1 g/liter adenine, 1 g/liter me-
thionine, 1.5 g/liter leucine, 1.5 g/liter lysine, 1 g/liter histidine, and 20 g/liter
casamino acids (Difco). Crosses and transformations were done using stan-
dard techniques.
The 3myc–Cod1p allele expressed in RHY1870 (Table I) was constructed
using a PCR epitope-tagging method (Schneider et al., 1995). URA3 and the
flanking myc epitope tags from pMPY–3xMYC were amplified with primers
oRH1190 and oRH1191. The primers added sequences homologous to the 5 
end of COD1. Yeast were transformed with the PCR product and selected for
acquisition of uracil prototrophy. Transformants were screened by the fluores-
cence plate assay for the Cod
  phenotype. Cod
 , Ura
  candidates were
grown in YPD to allow “pop-out” of URA3 mediated by the direct repeats of
the myc epitope tag followed by counterselection for loss of URA3 on media
containing 5-fluoroorotic acid. The resulting Ura
 , Cod
  candidates were then
tested for expression of the 3myc–Cod1p by western analysis.
The cod1 ::KanMX allele in RHY1722 (HMG2, cod1 ::KanMX) was
constructed by PCR-mediated disruption of the cod1 ::LEU2 allele from
RHY1402, which was derived from a cross of RHY792 and RHY1202 (Cro-
nin et al., 2000). The resulting strain (RHY1401) was crossed to RHY795
(HMG2, ura3-52). Sporulation and dissection yielded RHY1722.
RHY1708 (1MYC::HMG2) and RHY1709 (1MYC::HMG2, cod1 ::
LEU2) were used for  -galactosidase assays. They were constructed by
treatment of RHY791 and RHY1202 (Cronin et al., 2000) with 5-fluoro-
orotic acid. The  -galactosidase reporter plasmids were transformed into
the strains using standard techniques.
hac1  strains were constructed as follows. RHY1647 (hac1 ::URA3,
COD1) and RHY1664 (hac1 ::URA3, COD1) were constructed by trans-
forming RHY534 and RHY872, respectively, with the BamHI fragment of
pHAKO (Cox and Walter, 1996). RHY534 is a diploid version of JRY1159
(Hampton and Rine, 1994). RHY1884 was constructed by transforming
MYY290 (Smith and Yaffe, 1991) with the BamHI fragment of pHAKO
(Cox and Walter, 1996). RHY2179 (pmr1 ::HIS3) was constructed by
transforming MYY291 (Smith and Yaffe, 1991) with the AatII–AatII frag-
ment from pL127-6 (Cunningham and Fink, 1994b). RHY2277 was iso-
lated from a cross of RHY2179 and RHY1884.
Growth curves
Susceptibility of mutants to DTT, tunicamycin, MnCl2, and other divalent
cations was tested in minimal media. Susceptibility to MnCl2, CaCl2, and
EGTA was tested in liquid YPD buffered with succinate to pH 5.5. Low-
density liquid cultures of wild-type or mutant cells were used to serially di-
lute the tested agent. The resulting cultures were incubated and measured
for optical density at 600 nm.
Immunofluorescence microscopy
Immunofluorescence was performed essentially as described in detail previ-
ously (Rossanese et al., 1999), except that the cells were adhered to a multi-
well slide instead of a coverslip. Images were captured using a DeltaVision
confocal microscope and processed with the accompanying software.
 -Galactosidase assays
 -Galactosidase assays were performed as previously described (Guarente,
1983), except that freeze–thawing in liquid nitrogen was used to lyse cells.
Subcellular fractionation
Fractionation was performed as described by Roberg et al., 1997. Protein from
each fraction was separated by SDS-PAGE, transferred to nitrocellulose,
probed with the appropriate antibodies, and detected by chemiluminescence
using the ECL system. NIH Image 1.6 was used to determine signal intensity.
Table I. Yeast strains
Strain Genotype Reference
RHY791 MATa hmg2::HIS3::1mycHMG2 ura3-52::URA3::HMG2::GFP Cronin et al., 2000
RHY792 MAT  hmg2::HIS3::1mycHMG2 ura3-52::URA3::HMG2::GFP Cronin et al., 2000
RHY811 MATa hmg2::HIS3::1mycHMG2 ura3-52::URA3::HMG2::GFP cod1-1 Cronin et al., 2000
RHY812 MAT  hmg2::HIS3::1mycHMG2 ura3-52::URA3::HMG2::GFP cod1-1 Cronin et al., 2000
RHY871 MATa hmg2::HIS3::1mycHMG2 ura3-52:LEU2::HMG2::GFP Cronin et al., 2000
RHY872 MAT  hmg2::HIS3::1mycHMG2 ura3-52:LEU2::HMG2::GFP Cronin et al., 2000
RHY910 MATa hmg2::HIS3::1mycHMG2 ura3-52:LEU2::HMG2::GFP cod1-1 Cronin et al., 2000
RHY911 MAT  hmg2::HIS3::1mycHMG2 ura3-52:LEU2::HMG2::GFP cod1-1 Cronin et al., 2000
RHY1647 MAT  HMG2 ura3-52 hac1 ::URA3 This study
RHY1401 MAT  hmg2::HIS3::1mycHMG2 ura3-52::URA3::HMG2::GFP  cod1 ::KanMX This study
RHY1402 MAT  hmg2::HIS3::1mycHMG2 ura3-52::URA3::HMG2::GFP  cod1 ::LEU2 This study
RHY1664 MAT  hmg2::HIS3::1mycHMG2 ura3-52:LEU2::HMG2::GFP hac1 ::URA3 This study
RHY1722 MATa HMG2 ura3-52 cod1 ::KanMX This study
RHY1708 MATa hmg2::HIS3::1mycHMG2 ura3-52 This study
RHY1709 MATa hmg2::HIS3::1mycHMG2 ura3-52 cod1 ::LEU2 This study
RHY1870 MAT  HMG2 ura3-52 3myc::COD1 This study
MYY290 MATa ura3, his3, leu2 Smith and Yaffe, 1991
MYY291 MAT  ura3, his3, leu2 Smith and Yaffe, 1991
RHY1884 MATa ura3, his3, hac1 ::URA3 This study
RHY2179 MAT  ura3, his3, leu2, pmr1 ::HIS3 This study
RHY2277 MATa ura3, his3, hac1 ::URA3, pmr1 ::HIS This study
RHY2681 MAT  hmg2::HIS3::1mycHMG2 ura3-52::LEU2::HMG2::GFP  cod1 ::KanMX This study
CS601A MATa ura3-52::URA3 Suzuki and Shimma, 1999
CS601B MAT  pmr1 ::LEU2 ura3-52 Suzuki and Shimma, 1999
CS601C MATa spf1 ::TRP1 ura3-52 Suzuki and Shimma, 1999
CS601D MAT  spf1 ::TRP1 pmr1 ::LEU2 ura3-52 Suzuki and Shimma, 1999 Cod1p and ER function | Cronin et al. 1027
Flow cytometry
Analysis of GFP fluorescence in living cells by flow microfluorimetry was
performed on a Becton Dickinson FACScalibur
® flow microfluorimeter us-
ing settings appropriate for GFP. Strains were typically grown into early log
phase in minimal media. After addition of drugs, cultures were allowed to
incubate 4 h before analysis.
ICP-OES
The total amount of calcium and other ions in whole cells and subcellular
fractions was determined by ICP-OES. To determine the total ion content
of whole cells, cells were grown in YPD, pH 5.5, to OD600 of 1.5 ml of the
culture was collected by vacuum filtration onto 0.4- m filters. The cells
were then washed with 5 ml deionized water. The filters were transferred
to microcentrifuge tubes and digested in 500  l of 33% nitric acid over-
night at 65 C. Samples were diluted with 3 ml of deionized water before
analysis using a PerkinElmer Optima 3000XL spectrometer and software.
Solubilization and purification of histidine-tagged Cod1p
9HIS–HA–Cod1p was prepared by detergent extraction of the protein from
ER membranes followed by nickel affinity chromatography. ER membranes
were prepared by sucrose gradient centrifugation. Before harvesting, cells
were treated with 10 mM sodium azide. The cells were washed in 10 mM so-
dium azide, 5 mM Tris, pH 7.5, and then resuspended in lysis buffer (4 M sor-
bitol, 1 mM EDTA, 0.1 M KxHxPO4, pH 7.5) plus protease inhibitors (10 mM
PMSF, 2  g/ml chymostatin, 1  g/ml leupeptin, 1  g/ml pepstatin) so that the
packed yeast cells made up one third of the volume. The cells lysed with four
30-s pulses with 1-min intervals in a Bead Beater
® (BioSpec Products, Inc.).
The crude lysates was clarified by centrifugation at 350 g in a Sorvall SS-34
rotor. The clarified lysates were loaded onto a sucrose step gradient and cen-
trifuged for 2 h at 174,000 g in a Beckman Coulter SW28 rotor. ER mem-
branes containing 9HIS–HA–Cod1p were collected from the interface be-
tween 30% and 54% sucrose. The collected membranes were diluted with
an equal volume of P&R buffer (0.5 M sucrose, 10 mM MES/KOH, pH 6, 150
mM potassium chloride) with protease inhibitors (1 mM PMSF, 2  g/ml chy-
mostatin, 1  g/ml leupeptin, 1  g/ml pepstatin). The membranes were pel-
leted by centrifugation for 1 h at 174,000 g. The pelleted membranes were
resuspended in P&R buffer with protease inhibitors and stored at  90 C in
110- l aliquots. Protein concentration in the membranes was measured us-
ing the BCA assay (Pierce Chemical Co.).
Detergent extracts of the membranes were prepared as follows. 10 mg
of membrane was suspended in 10 ml of S-buffer (20 mM Hepes/Tris, pH
7.0, 20% glycerol, 0.5% E. coli lipid extract, 6 mM  -mercaptoethanol, 10
mM imidazole, protease inhibitors, and 1.5% n-octyl- -D-glucopyrano-
side) and allowed to shake gently at 4 C for 2.5 h. The resulting suspension
was centrifuged at 100,000 g for 1 h to pellet insoluble material.
The detergent-solubilized 9HIS–HA–Cod1p was then purified by nickel
affinity chromatography. 250  l of NTA-Ni agarose beads (QIAGEN) per
milliliter of solubilized membranes was washed twice with deionized wa-
ter and then twice with S-buffer. The equilibrated beads were added to the
detergent extract and gently shaken at 4 C for 30 min. The extract with
beads was then transferred to 2 ml Micro Bio-Spin columns (Bio-Rad Labo-
ratories). Unbound material was allowed to flow through by gravity elu-
tion. Each column was washed twice with 1 ml of S-buffer plus 200 mM
NaCl, and the column was washed a third time with S-buffer. 9HIS–HA–
Cod1p was eluted after a 5-min incubation with 0.2 ml per column of
S-buffer plus 300 mM imidazole. The eluted material was immediately fro-
zen in a dry ice–ethanol bath and stored at  90 C in 60- l aliquots.
Assaying ATPase activity
ATPase activity was measured using the radiometric assay described previ-
ously (Bais, 1975; Mandal et al., 2000) with some modifications. Assays
were done in a 50- l volume and generally contained 50 mM Hepes/Tris,
pH 7.0, 100 mM KCl, 5 mM MgCl2, 1 mM EDTA. [ 
32P]ATP (30 Ci/mmol;
Amersham Pharmacia Biotech) was diluted 10-fold with 1 mM NaATP to
the final concentration desired. Variations in the assay conditions are noted
in the figures. The concentrations of free ions and MgATP complexes were
calculated using WINMAXC v2.05 (Bers et al., 1994) with supplementary
constants from Data for Biochemical Research (Dawson et al., 1986). EDTA
was excluded from experiments determining the effect of transition metals
on Cod1p, because the high affinity of EDTA (and other chelators) for tran-
sition metals prevented accurate determination of the free ion within the
desired range. Solutions were checked for contaminating ions by ICP-OES.
Vanadate was prepared by the method of Gordon (1991).
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